- Investing Ideas
- /
- Global Pharmaceuticals & Biotech Top Stock Picks from Analysts
Global Pharmaceuticals & Biotech Top Stock Picks from Analysts
Results
834
Companies which are more than 50% undervalued based on analyst price target.
834 companies
Amicus Therapeutics
Market Cap: US$1.9b
A biotechnology company, focuses on discovering, developing, and delivering novel medicines for rare diseases in the United States and internationally.
FOLD
US$5.98
7D
-10.3%
1Y
-35.2%
ImmunityBio
Market Cap: US$1.8b
A commercial stage biotechnology company, develops next-generation therapies that bolster the natural immune systems to defeat cancers and infectious diseases.
IBRX
US$2.07
7D
-18.5%
1Y
-74.5%
CG Oncology
Market Cap: US$1.8b
A late-stage clinical biopharmaceutical company, develops and commercializes backbone bladder-sparing therapeutics for patients with bladder cancer.
CGON
US$23.74
7D
-18.3%
1Y
-16.7%
Travere Therapeutics
Market Cap: US$1.8b
A biopharmaceutical company, identifies, develops, and delivers therapies to people living with rare kidney and metabolic diseases in the United States.
TVTX
US$20.02
7D
-5.3%
1Y
217.8%
Recursion Pharmaceuticals
Market Cap: US$1.8b
Operates as a clinical-stage biotechnology company, engages in the decoding biology and chemistry by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery in the United States.
RXRX
US$4.33
7D
-24.0%
1Y
-49.7%
Bausch Health Companies
Market Cap: US$1.7b
Operates as a diversified specialty pharmaceutical and medical device company, develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, generic pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health in the United States and internationally.
BHC
US$4.59
7D
-15.3%
1Y
-33.3%
PeptiDream
Market Cap: JP¥248.4b
A biopharmaceutical company, engages in the discovery and development of constrained peptides, small molecules, and peptide-drug conjugate therapeutics.
4587
JP¥1,916.50
7D
-5.1%
1Y
-2.3%
Beam Therapeutics
Market Cap: US$1.7b
A biotechnology company, engages in the development of precision genetic medicines for patients suffering from serious diseases in the United States.
BEAM
US$17.41
7D
-14.0%
1Y
-18.1%
Arrowhead Pharmaceuticals
Market Cap: US$1.7b
Develops medicines for the treatment of intractable diseases in the United States.
ARWR
US$13.03
7D
-9.6%
1Y
-41.0%
Jiangsu Sinopep-Allsino Biopharmaceutical
Market Cap: CN¥11.9b
A biomedical company, engages in the research and development, production, sale, and technical service of peptides and small molecule drugs in China.
688076
CN¥53.14
7D
0.4%
1Y
-13.1%
Centessa Pharmaceuticals
Market Cap: US$1.7b
A clinical-stage pharmaceutical company, discovers, develops, and delivers medicines.
CNTA
US$12.30
7D
-9.6%
1Y
37.1%
BioArctic
Market Cap: SEK 15.8b
Develops biological drugs for patients with disorders of the central nervous system in Sweden.
BIOA B
SEK 178.20
7D
-9.2%
1Y
-12.2%
Agios Pharmaceuticals
Market Cap: US$1.6b
A biopharmaceutical company, discovers and develops medicines in the field of cellular metabolism in the United States.
AGIO
US$27.32
7D
-9.2%
1Y
-17.2%
Arcutis Biotherapeutics
Market Cap: US$1.6b
A biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases.
ARQT
US$13.53
7D
-11.2%
1Y
72.6%
Jubilant Pharmova
Market Cap: ₹137.4b
Operates as an integrated pharmaceutical company in India, the Americas, Europe, and internationally.
530019
₹867.50
7D
-4.3%
1Y
24.4%
Endo
Market Cap: US$1.6b
A specialty pharmaceutical company, develops, manufactures, markets, and sells various pharmaceutical products in the United States and internationally.
NDOI
US$21.44
7D
0.9%
1Y
n/a
IDEAYA Biosciences
Market Cap: US$1.6b
A precision medicine oncology company, discovers and develops targeted therapeutics for patient populations selected using molecular diagnostics in the United States.
IDYA
US$17.42
7D
-16.8%
1Y
-57.7%
Janux Therapeutics
Market Cap: US$1.6b
A clinical stage biopharmaceutical company, develops immunotherapies based on Tumor Activated T Cell Engager (TRACTr) and Tumor Activated Immunomodulator (TRACIr) platforms technology to treat patients with cancer.
JANX
US$25.56
7D
-22.3%
1Y
-47.8%
Square Pharmaceuticals
Market Cap: ৳189.0b
Manufactures, markets, and sells pharmaceutical products in Bangladesh and internationally.
SQURPHARMA
৳213.20
7D
-0.4%
1Y
0.5%
Edgewise Therapeutics
Market Cap: US$1.5b
A biopharmaceutical company, discovers, develops, and commercializes therapies for the treatment of muscle disorders.
EWTX
US$14.58
7D
-13.8%
1Y
-20.5%
Structure Therapeutics
Market Cap: US$1.5b
A clinical stage global biopharmaceutical company, develops and delivers novel oral small molecule therapeutics to treat various chronic diseases with unmet medical needs in the United States.
GPCR
US$25.57
7D
-5.6%
1Y
-28.6%
Disc Medicine
Market Cap: US$1.5b
A clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases in the United States.
IRON
US$44.24
7D
-10.6%
1Y
45.7%
Immunocore Holdings
Market Cap: US$1.5b
A commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases.
IMCR
US$28.40
7D
-6.8%
1Y
-51.8%
Shanghai Haohai Biological Technology
Market Cap: HK$11.5b
Shanghai Haohai Biological Technology Co., Ltd.
6826
HK$23.30
7D
-4.7%
1Y
-22.9%
MannKind
Market Cap: US$1.4b
A biopharmaceutical company, focuses on the development and commercialization of therapeutic products and services for endocrine and orphan lung diseases in the United States.
MNKD
US$4.56
7D
-8.8%
1Y
5.6%
Vera Therapeutics
Market Cap: US$1.4b
A clinical stage biotechnology company, focuses on the development and commercialization of transformative treatments for patients with serious immunological diseases.
VERA
US$21.71
7D
-14.2%
1Y
-47.5%
Mesoblast
Market Cap: AU$2.2b
Engages in the development of regenerative medicine products in Australia, the United States, Singapore, and Switzerland.
MSB
AU$1.71
7D
-7.6%
1Y
60.1%
Green Thumb Industries
Market Cap: CA$1.9b
Manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States.
GTII
CA$7.71
7D
-14.0%
1Y
-55.9%
Hualan Biological Vaccine
Market Cap: CN¥9.6b
Engages in the research, development, production, and sale of vaccines in China.
301207
CN¥16.14
7D
2.1%
1Y
-28.0%
ARS Pharmaceuticals
Market Cap: US$1.3b
A biopharmaceutical company, develops and commercializes treatments for severe allergic reactions.
SPRY
US$13.44
7D
-7.1%
1Y
53.8%
Liquidia
Market Cap: US$1.3b
A biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States.
LQDA
US$15.26
7D
-3.6%
1Y
26.5%
Celldex Therapeutics
Market Cap: US$1.3b
A biopharmaceutical company, engages in developing therapeutic antibodies for patients with severe inflammatory, allergic, autoimmune, and other diseases.
CLDX
US$18.33
7D
-11.3%
1Y
-54.1%
Dyne Therapeutics
Market Cap: US$1.3b
A clinical-stage neuromuscular disease company, focuses on discovering and developing therapeutics for neuromuscular diseases in the United States.
DYN
US$11.41
7D
-3.8%
1Y
-56.1%
Azenta
Market Cap: US$1.3b
Provides biological and chemical compound sample exploration and management solutions for the life sciences market in the United States, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally.
AZTA
US$26.77
7D
-0.7%
1Y
-48.1%
Zhejiang Xianju PharmaceuticalLtd
Market Cap: CN¥9.2b
Manufactures and sells steroids and hormones worldwide.
002332
CN¥9.26
7D
3.1%
1Y
-24.7%
Voronoi
Market Cap: ₩1.7t
Researches, develops, and discovers small molecule kinase inhibitors in South Korea.
A310210
₩94,400.00
7D
-3.9%
1Y
190.9%